Table of Content

1 Non-opioid Pain Med Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Med
1.2 Non-opioid Pain Med Segment by Type
1.2.1 Global Non-opioid Pain Med Market Value Comparison by Type (2024-2034)
1.2.2 Diclofenac Sodium
1.2.3 Acetaminophen
1.2.4 Indomethacin
1.2.5 Ibuprofen
1.2.6 Aspirin
1.2.7 Others
1.3 Non-opioid Pain Med Segment by Application
1.3.1 Global Non-opioid Pain Med Market Value by Application: (2024-2034)
1.3.2 Mild Pain
1.3.3 Moderate Pain
1.4 Global Non-opioid Pain Med Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Med Revenue 2024-2034
1.4.2 Global Non-opioid Pain Med Sales 2024-2034
1.4.3 Global Non-opioid Pain Med Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 Non-opioid Pain Med Market Competition by Manufacturers
2.1 Global Non-opioid Pain Med Sales Market Share by Manufacturers (2024-2024)
2.2 Global Non-opioid Pain Med Revenue Market Share by Manufacturers (2024-2024)
2.3 Global Non-opioid Pain Med Average Price by Manufacturers (2024-2024)
2.4 Global Non-opioid Pain Med Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Non-opioid Pain Med, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Med, Product Type & Application
2.7 Non-opioid Pain Med Market Competitive Situation and Trends
2.7.1 Non-opioid Pain Med Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Med Players Market Share by Revenue
2.7.3 Global Non-opioid Pain Med Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Pain Med Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Med Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global Non-opioid Pain Med Global Non-opioid Pain Med Sales by Region: 2024-2034
3.2.1 Global Non-opioid Pain Med Sales by Region: 2024-2024
3.2.2 Global Non-opioid Pain Med Sales by Region: 2024-2034
3.3 Global Non-opioid Pain Med Global Non-opioid Pain Med Revenue by Region: 2024-2034
3.3.1 Global Non-opioid Pain Med Revenue by Region: 2024-2024
3.3.2 Global Non-opioid Pain Med Revenue by Region: 2024-2034
3.4 North America Non-opioid Pain Med Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Med Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America Non-opioid Pain Med Sales by Country (2024-2034)
3.4.3 North America Non-opioid Pain Med Revenue by Country (2024-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-opioid Pain Med Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Med Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe Non-opioid Pain Med Sales by Country (2024-2034)
3.5.3 Europe Non-opioid Pain Med Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Med Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Pain Med Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific Non-opioid Pain Med Sales by Country (2024-2034)
3.6.3 Asia Pacific Non-opioid Pain Med Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Non-opioid Pain Med Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Med Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America Non-opioid Pain Med Sales by Country (2024-2034)
3.7.3 Latin America Non-opioid Pain Med Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Med Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Med Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa Non-opioid Pain Med Sales by Country (2024-2034)
3.8.3 Middle East and Africa Non-opioid Pain Med Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Pain Med Sales by Type (2024-2034)
4.1.1 Global Non-opioid Pain Med Sales by Type (2024-2024)
4.1.2 Global Non-opioid Pain Med Sales by Type (2024-2034)
4.1.3 Global Non-opioid Pain Med Sales Market Share by Type (2024-2034)
4.2 Global Non-opioid Pain Med Revenue by Type (2024-2034)
4.2.1 Global Non-opioid Pain Med Revenue by Type (2024-2024)
4.2.2 Global Non-opioid Pain Med Revenue by Type (2024-2034)
4.2.3 Global Non-opioid Pain Med Revenue Market Share by Type (2024-2034)
4.3 Global Non-opioid Pain Med Price by Type (2024-2034)
5 Segment by Application
5.1 Global Non-opioid Pain Med Sales by Application (2024-2034)
5.1.1 Global Non-opioid Pain Med Sales by Application (2024-2024)
5.1.2 Global Non-opioid Pain Med Sales by Application (2024-2034)
5.1.3 Global Non-opioid Pain Med Sales Market Share by Application (2024-2034)
5.2 Global Non-opioid Pain Med Revenue by Application (2024-2034)
5.2.1 Global Non-opioid Pain Med Revenue by Application (2024-2024)
5.2.2 Global Non-opioid Pain Med Revenue by Application (2024-2034)
5.2.3 Global Non-opioid Pain Med Revenue Market Share by Application (2024-2034)
5.3 Global Non-opioid Pain Med Price by Application (2024-2034)
6 Key Companies Profiled
6.1 WEX Pharmaceuticals Inc.
6.1.1 WEX Pharmaceuticals Inc. Corporation Information
6.1.2 WEX Pharmaceuticals Inc. Description and Business Overview
6.1.3 WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.1.4 WEX Pharmaceuticals Inc. Non-opioid Pain Med Product Portfolio
6.1.5 WEX Pharmaceuticals Inc. Recent Developments/Updates
6.2 BASF
6.2.1 BASF Corporation Information
6.2.2 BASF Description and Business Overview
6.2.3 BASF Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.2.4 BASF Non-opioid Pain Med Product Portfolio
6.2.5 BASF Recent Developments/Updates
6.3 Xinhua Pharm
6.3.1 Xinhua Pharm Corporation Information
6.3.2 Xinhua Pharm Description and Business Overview
6.3.3 Xinhua Pharm Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Xinhua Pharm Non-opioid Pain Med Product Portfolio
6.3.5 Xinhua Pharm Recent Developments/Updates
6.4 Johnson & Johnson（McNeil Consumer Healthcare）
6.4.1 Johnson & Johnson（McNeil Consumer Healthcare） Corporation Information
6.4.2 Johnson & Johnson（McNeil Consumer Healthcare） Description and Business Overview
6.4.3 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product Portfolio
6.4.5 Johnson & Johnson（McNeil Consumer Healthcare） Recent Developments/Updates
6.5 Granules Biocause
6.5.1 Granules Biocause Corporation Information
6.5.2 Granules Biocause Description and Business Overview
6.5.3 Granules Biocause Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Granules Biocause Non-opioid Pain Med Product Portfolio
6.5.5 Granules Biocause Recent Developments/Updates
6.6 Novacyl
6.6.1 Novacyl Corporation Information
6.6.2 Novacyl Description and Business Overview
6.6.3 Novacyl Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Novacyl Non-opioid Pain Med Product Portfolio
6.6.5 Novacyl Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.4.4 Pfizer Non-opioid Pain Med Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Hisoar
6.8.1 Hisoar Corporation Information
6.8.2 Hisoar Description and Business Overview
6.8.3 Hisoar Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.8.4 Hisoar Non-opioid Pain Med Product Portfolio
6.8.5 Hisoar Recent Developments/Updates
6.9 Anant Pharmaceuticals Pvt. Ltd.
6.9.1 Anant Pharmaceuticals Pvt. Ltd. Corporation Information
6.9.2 Anant Pharmaceuticals Pvt. Ltd. Description and Business Overview
6.9.3 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product Portfolio
6.9.5 Anant Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
6.10 Strides Shasun
6.10.1 Strides Shasun Corporation Information
6.10.2 Strides Shasun Description and Business Overview
6.10.3 Strides Shasun Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Strides Shasun Non-opioid Pain Med Product Portfolio
6.10.5 Strides Shasun Recent Developments/Updates
6.11 SI Group
6.11.1 SI Group Corporation Information
6.11.2 SI Group Non-opioid Pain Med Description and Business Overview
6.11.3 SI Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.11.4 SI Group Non-opioid Pain Med Product Portfolio
6.11.5 SI Group Recent Developments/Updates
6.12 Elam Pharma
6.12.1 Elam Pharma Corporation Information
6.12.2 Elam Pharma Non-opioid Pain Med Description and Business Overview
6.12.3 Elam Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.12.4 Elam Pharma Non-opioid Pain Med Product Portfolio
6.12.5 Elam Pharma Recent Developments/Updates
6.13 AdvaCare Pharma
6.13.1 AdvaCare Pharma Corporation Information
6.13.2 AdvaCare Pharma Non-opioid Pain Med Description and Business Overview
6.13.3 AdvaCare Pharma Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.13.4 AdvaCare Pharma Non-opioid Pain Med Product Portfolio
6.13.5 AdvaCare Pharma Recent Developments/Updates
6.14 IOL
6.14.1 IOL Corporation Information
6.14.2 IOL Non-opioid Pain Med Description and Business Overview
6.14.3 IOL Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.14.4 IOL Non-opioid Pain Med Product Portfolio
6.14.5 IOL Recent Developments/Updates
6.15 Jingye Group
6.15.1 Jingye Group Corporation Information
6.15.2 Jingye Group Non-opioid Pain Med Description and Business Overview
6.15.3 Jingye Group Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.15.4 Jingye Group Non-opioid Pain Med Product Portfolio
6.15.5 Jingye Group Recent Developments/Updates
6.16 NS Chemicals
6.16.1 NS Chemicals Corporation Information
6.16.2 NS Chemicals Non-opioid Pain Med Description and Business Overview
6.16.3 NS Chemicals Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.16.4 NS Chemicals Non-opioid Pain Med Product Portfolio
6.16.5 NS Chemicals Recent Developments/Updates
6.17 Hunan Zhongnan Pharmaceutical
6.17.1 Hunan Zhongnan Pharmaceutical Corporation Information
6.17.2 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Description and Business Overview
6.17.3 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.17.4 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product Portfolio
6.17.5 Hunan Zhongnan Pharmaceutical Recent Developments/Updates
6.18 Nanjing Pharmaceutical Factory
6.18.1 Nanjing Pharmaceutical Factory Corporation Information
6.18.2 Nanjing Pharmaceutical Factory Non-opioid Pain Med Description and Business Overview
6.18.3 Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.18.4 Nanjing Pharmaceutical Factory Non-opioid Pain Med Product Portfolio
6.18.5 Nanjing Pharmaceutical Factory Recent Developments/Updates
6.19 Huayin Jinqiancheng Pharmaceutical Co., Ltd.
6.19.1 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Corporation Information
6.19.2 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Description and Business Overview
6.19.3 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.19.4 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product Portfolio
6.19.5 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Mallinckrodt Pharmaceuticals
6.20.1 Mallinckrodt Pharmaceuticals Corporation Information
6.20.2 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Description and Business Overview
6.20.3 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales, Revenue and Gross Margin (2024-2024)
6.20.4 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product Portfolio
6.20.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Med Industry Chain Analysis
7.2 Non-opioid Pain Med Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Med Production Mode & Process
7.4 Non-opioid Pain Med Sales and Marketing
7.4.1 Non-opioid Pain Med Sales Channels
7.4.2 Non-opioid Pain Med Distributors
7.5 Non-opioid Pain Med Customers
8 Non-opioid Pain Med Market Dynamics
8.1 Non-opioid Pain Med Industry Trends
8.2 Non-opioid Pain Med Market Drivers
8.3 Non-opioid Pain Med Market Challenges
8.4 Non-opioid Pain Med Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-opioid Pain Med Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Non-opioid Pain Med Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Non-opioid Pain Med Market Competitive Situation by Manufacturers in 2022
Table 4. Global Non-opioid Pain Med Sales (K Units) of Key Manufacturers (2024-2024)
Table 5. Global Non-opioid Pain Med Sales Market Share by Manufacturers (2024-2024)
Table 6. Global Non-opioid Pain Med Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global Non-opioid Pain Med Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market Non-opioid Pain Med Average Price (US$/Unit) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of Non-opioid Pain Med, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Non-opioid Pain Med, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Pain Med, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Pain Med, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Pain Med by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Med as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Pain Med Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global Non-opioid Pain Med Sales by Region (2024-2024) & (K Units)
Table 18. Global Non-opioid Pain Med Sales Market Share by Region (2024-2024)
Table 19. Global Non-opioid Pain Med Sales by Region (2024-2034) & (K Units)
Table 20. Global Non-opioid Pain Med Sales Market Share by Region (2024-2034)
Table 21. Global Non-opioid Pain Med Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global Non-opioid Pain Med Revenue Market Share by Region (2024-2024)
Table 23. Global Non-opioid Pain Med Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Non-opioid Pain Med Revenue Market Share by Region (2024-2034)
Table 25. North America Non-opioid Pain Med Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America Non-opioid Pain Med Sales by Country (2024-2024) & (K Units)
Table 27. North America Non-opioid Pain Med Sales by Country (2024-2034) & (K Units)
Table 28. North America Non-opioid Pain Med Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America Non-opioid Pain Med Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Non-opioid Pain Med Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Non-opioid Pain Med Sales by Country (2024-2024) & (K Units)
Table 32. Europe Non-opioid Pain Med Sales by Country (2024-2034) & (K Units)
Table 33. Europe Non-opioid Pain Med Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe Non-opioid Pain Med Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Non-opioid Pain Med Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Non-opioid Pain Med Sales by Region (2024-2024) & (K Units)
Table 37. Asia Pacific Non-opioid Pain Med Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Non-opioid Pain Med Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific Non-opioid Pain Med Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Non-opioid Pain Med Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Non-opioid Pain Med Sales by Country (2024-2024) & (K Units)
Table 42. Latin America Non-opioid Pain Med Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Non-opioid Pain Med Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America Non-opioid Pain Med Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Non-opioid Pain Med Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Non-opioid Pain Med Sales by Country (2024-2024) & (K Units)
Table 47. Middle East & Africa Non-opioid Pain Med Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Non-opioid Pain Med Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa Non-opioid Pain Med Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Non-opioid Pain Med Sales (K Units) by Type (2024-2024)
Table 51. Global Non-opioid Pain Med Sales (K Units) by Type (2024-2034)
Table 52. Global Non-opioid Pain Med Sales Market Share by Type (2024-2024)
Table 53. Global Non-opioid Pain Med Sales Market Share by Type (2024-2034)
Table 54. Global Non-opioid Pain Med Revenue (US$ Million) by Type (2024-2024)
Table 55. Global Non-opioid Pain Med Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Non-opioid Pain Med Revenue Market Share by Type (2024-2024)
Table 57. Global Non-opioid Pain Med Revenue Market Share by Type (2024-2034)
Table 58. Global Non-opioid Pain Med Price (US$/Unit) by Type (2024-2024)
Table 59. Global Non-opioid Pain Med Price (US$/Unit) by Type (2024-2034)
Table 60. Global Non-opioid Pain Med Sales (K Units) by Application (2024-2024)
Table 61. Global Non-opioid Pain Med Sales (K Units) by Application (2024-2034)
Table 62. Global Non-opioid Pain Med Sales Market Share by Application (2024-2024)
Table 63. Global Non-opioid Pain Med Sales Market Share by Application (2024-2034)
Table 64. Global Non-opioid Pain Med Revenue (US$ Million) by Application (2024-2024)
Table 65. Global Non-opioid Pain Med Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Non-opioid Pain Med Revenue Market Share by Application (2024-2024)
Table 67. Global Non-opioid Pain Med Revenue Market Share by Application (2024-2034)
Table 68. Global Non-opioid Pain Med Price (US$/Unit) by Application (2024-2024)
Table 69. Global Non-opioid Pain Med Price (US$/Unit) by Application (2024-2034)
Table 70. WEX Pharmaceuticals Inc. Corporation Information
Table 71. WEX Pharmaceuticals Inc. Description and Business Overview
Table 72. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 73. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product
Table 74. WEX Pharmaceuticals Inc. Recent Developments/Updates
Table 75. BASF Corporation Information
Table 76. BASF Description and Business Overview
Table 77. BASF Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 78. BASF Non-opioid Pain Med Product
Table 79. BASF Recent Developments/Updates
Table 80. Xinhua Pharm Corporation Information
Table 81. Xinhua Pharm Description and Business Overview
Table 82. Xinhua Pharm Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 83. Xinhua Pharm Non-opioid Pain Med Product
Table 84. Xinhua Pharm Recent Developments/Updates
Table 85. Johnson & Johnson（McNeil Consumer Healthcare） Corporation Information
Table 86. Johnson & Johnson（McNeil Consumer Healthcare） Description and Business Overview
Table 87. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 88. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product
Table 89. Johnson & Johnson（McNeil Consumer Healthcare） Recent Developments/Updates
Table 90. Granules Biocause Corporation Information
Table 91. Granules Biocause Description and Business Overview
Table 92. Granules Biocause Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 93. Granules Biocause Non-opioid Pain Med Product
Table 94. Granules Biocause Recent Developments/Updates
Table 95. Novacyl Corporation Information
Table 96. Novacyl Description and Business Overview
Table 97. Novacyl Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 98. Novacyl Non-opioid Pain Med Product
Table 99. Novacyl Recent Developments/Updates
Table 100. Pfizer Corporation Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 103. Pfizer Non-opioid Pain Med Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Hisoar Corporation Information
Table 106. Hisoar Description and Business Overview
Table 107. Hisoar Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 108. Hisoar Non-opioid Pain Med Product
Table 109. Hisoar Recent Developments/Updates
Table 110. Anant Pharmaceuticals Pvt. Ltd. Corporation Information
Table 111. Anant Pharmaceuticals Pvt. Ltd. Description and Business Overview
Table 112. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 113. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product
Table 114. Anant Pharmaceuticals Pvt. Ltd. Recent Developments/Updates
Table 115. Strides Shasun Corporation Information
Table 116. Strides Shasun Description and Business Overview
Table 117. Strides Shasun Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 118. Strides Shasun Non-opioid Pain Med Product
Table 119. Strides Shasun Recent Developments/Updates
Table 120. SI Group Corporation Information
Table 121. SI Group Description and Business Overview
Table 122. SI Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 123. SI Group Non-opioid Pain Med Product
Table 124. SI Group Recent Developments/Updates
Table 125. Elam Pharma Corporation Information
Table 126. Elam Pharma Description and Business Overview
Table 127. Elam Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 128. Elam Pharma Non-opioid Pain Med Product
Table 129. Elam Pharma Recent Developments/Updates
Table 130. AdvaCare Pharma Corporation Information
Table 131. AdvaCare Pharma Description and Business Overview
Table 132. AdvaCare Pharma Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 133. AdvaCare Pharma Non-opioid Pain Med Product
Table 134. AdvaCare Pharma Recent Developments/Updates
Table 135. IOL Corporation Information
Table 136. IOL Description and Business Overview
Table 137. IOL Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 138. IOL Non-opioid Pain Med Product
Table 139. IOL Recent Developments/Updates
Table 140. Jingye Group Corporation Information
Table 141. Jingye Group Description and Business Overview
Table 142. Jingye Group Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 143. Jingye Group Non-opioid Pain Med Product
Table 144. Jingye Group Recent Developments/Updates
Table 145. NS Chemicals Corporation Information
Table 146. NS Chemicals Description and Business Overview
Table 147. NS Chemicals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 148. NS Chemicals Non-opioid Pain Med Product
Table 149. NS Chemicals Recent Developments/Updates
Table 150. Hunan Zhongnan Pharmaceutical Corporation Information
Table 151. Hunan Zhongnan Pharmaceutical Description and Business Overview
Table 152. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 153. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product
Table 154. Hunan Zhongnan Pharmaceutical Recent Developments/Updates
Table 155. Nanjing Pharmaceutical Factory Corporation Information
Table 156. Nanjing Pharmaceutical Factory Description and Business Overview
Table 157. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 158. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product
Table 159. Nanjing Pharmaceutical Factory Recent Developments/Updates
Table 160. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Corporation Information
Table 161. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Description and Business Overview
Table 162. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 163. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product
Table 164. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 165. Mallinckrodt Pharmaceuticals Corporation Information
Table 166. Mallinckrodt Pharmaceuticals Description and Business Overview
Table 167. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 168. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product
Table 169. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Non-opioid Pain Med Distributors List
Table 173. Non-opioid Pain Med Customers List
Table 174. Non-opioid Pain Med Market Trends
Table 175. Non-opioid Pain Med Market Drivers
Table 176. Non-opioid Pain Med Market Challenges
Table 177. Non-opioid Pain Med Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Pain Med
Figure 2. Global Non-opioid Pain Med Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Non-opioid Pain Med Market Share by Type in 2022 & 2034
Figure 4. Diclofenac Sodium Product Picture
Figure 5. Acetaminophen Product Picture
Figure 6. Indomethacin Product Picture
Figure 7. Ibuprofen Product Picture
Figure 8. Aspirin Product Picture
Figure 9. Others Product Picture
Figure 10. Global Non-opioid Pain Med Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Non-opioid Pain Med Market Share by Application in 2022 & 2034
Figure 12. Mild Pain
Figure 13. Moderate Pain
Figure 14. Global Non-opioid Pain Med Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Non-opioid Pain Med Market Size (2024-2034) & (US$ Million)
Figure 16. Global Non-opioid Pain Med Sales (2024-2034) & (K Units)
Figure 17. Global Non-opioid Pain Med Average Price (US$/Unit) & (2024-2034)
Figure 18. Non-opioid Pain Med Report Years Considered
Figure 19. Non-opioid Pain Med Sales Share by Manufacturers in 2022
Figure 20. Global Non-opioid Pain Med Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Non-opioid Pain Med Players: Market Share by Revenue in 2022
Figure 22. Non-opioid Pain Med Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 23. Global Non-opioid Pain Med Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 24. North America Non-opioid Pain Med Sales Market Share by Country (2024-2034)
Figure 25. North America Non-opioid Pain Med Revenue Market Share by Country (2024-2034)
Figure 26. United States Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 27. Canada Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 28. Europe Non-opioid Pain Med Sales Market Share by Country (2024-2034)
Figure 29. Europe Non-opioid Pain Med Revenue Market Share by Country (2024-2034)
Figure 30. Germany Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. France Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. U.K. Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Italy Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 34. Russia Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 35. Asia Pacific Non-opioid Pain Med Sales Market Share by Region (2024-2034)
Figure 36. Asia Pacific Non-opioid Pain Med Revenue Market Share by Region (2024-2034)
Figure 37. China Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. Japan Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. South Korea Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. India Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Australia Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. China Taiwan Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Southeast Asia Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Latin America Non-opioid Pain Med Sales Market Share by Country (2024-2034)
Figure 45. Latin America Non-opioid Pain Med Revenue Market Share by Country (2024-2034)
Figure 46. Mexico Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 47. Brazil Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Argentina Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Middle East & Africa Non-opioid Pain Med Sales Market Share by Country (2024-2034)
Figure 50. Middle East & Africa Non-opioid Pain Med Revenue Market Share by Country (2024-2034)
Figure 51. Turkey Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. UAE Non-opioid Pain Med Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Non-opioid Pain Med by Type (2024-2034)
Figure 55. Global Revenue Market Share of Non-opioid Pain Med by Type (2024-2034)
Figure 56. Global Non-opioid Pain Med Price (US$/Unit) by Type (2024-2034)
Figure 57. Global Sales Market Share of Non-opioid Pain Med by Application (2024-2034)
Figure 58. Global Revenue Market Share of Non-opioid Pain Med by Application (2024-2034)
Figure 59. Global Non-opioid Pain Med Price (US$/Unit) by Application (2024-2034)
Figure 60. Non-opioid Pain Med Value Chain
Figure 61. Non-opioid Pain Med Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed